Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Anti-von Willebrand Factor Nanobody, Caplacizumab[2] Caplacizumab,
Von Willebrand factor human
[1] D11160 (Name: Caplacizumab)[1] VWF 💬[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬[1] 64
2Anti-von Willebrand Factor Nanobody, INN = Caplacizumab[2] Caplacizumab,
Von Willebrand factor human
[1] D11160 (Name: Caplacizumab)[1] VWF 💬[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬[1] 64
3CAPLACIZUMAB[1] Caplacizumab[1] D11160 (Name: Caplacizumab)[1] VWF 💬[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬[1] 64
4Caplacizumab (ALX-0081)[1] Caplacizumab[1] D11160 (Name: Caplacizumab)[1] VWF 💬[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬[1] 64
5Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081)[2] Caplacizumab,
Von Willebrand factor human
[1] D11160 (Name: Caplacizumab)[1] VWF 💬[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬[1] 64
6Caplacizumab (an anti-von Willebrand Factor Nanobody)[2] Caplacizumab,
Von Willebrand factor human
[1] D11160 (Name: Caplacizumab)[1] VWF 💬[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬[1] 64